Skip to main content

Home/ COSEE-West/ Group items tagged expansion

Rss Feed Group items tagged

Gwen Noda

The Impact of Conservation on the Status of the World's Vertebrates - 0 views

  •  
    "Using data for 25,780 species categorized on the International Union for Conservation of Nature Red List, we present an assessment of the status of the world's vertebrates. One-fifth of species are classified as Threatened, and we show that this figure is increasing: On average, 52 species of mammals, birds, and amphibians move one category closer to extinction each year. However, this overall pattern conceals the impact of conservation successes, and we show that the rate of deterioration would have been at least one-fifth again as much in the absence of these. Nonetheless, current conservation efforts remain insufficient to offset the main drivers of biodiversity loss in these groups: agricultural expansion, logging, overexploitation, and invasive alien species. "
Gwen Noda

Genetically Modified Salmon and Full Impact Assessment - 0 views

  •  
    As the U.S. Food and Drug Administration (FDA) considers approving a genetically modified (GM) Atlantic salmon (Salmo salar), it faces fundamental questions of risk analysis and impact assessment. The GM salmon-whose genome contains an inserted growth gene from Pacific chinook salmon (Oncorhynchus tshawytscha) and a switch-on gene from ocean pout (Zoarces americanus)-would be the first transgenic animal approved for human consumption in the United States (1, 2). But the mechanism for its approval, FDA's new animal drug application (NADA) process (2), narrowly examines only the risks of each GM salmon compared with a non-GM salmon (2, 3). This approach fails to acknowledge that the new product's attributes may affect total production and consumption of salmon. This potentially excludes major human health and environmental impacts, both benefits and risks. Regulators need to consider the full scope of such impacts in risk analyses to avoid unintended consequences (4), yet FDA does not consider ancillary benefits and risks from salmon market expansion (2, 3), a result of what may be an overly narrow interpretation of statutes.
Gwen Noda

Back from the dead: 800,000-year-old plankton - CBS News - 0 views

  •  
    Not really back from the dead: A single-celled alga that went extinct in the North Atlantic Ocean about 800,000 years ago has returned after drifting from the Pacific through the Arctic thanks to melting polar ice. And while its appearance marks the first trans-Arctic migration in modern times, scientists say it signals something potentially bigger.
1 - 5 of 5
Showing 20 items per page